Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Elimination af hepatitis C-virus i Danmark

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Surfactant therapy of respiratory distress syndrome

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. DBCG Kvalitetsdatabase for Brystkræft – resumé af årsrapport 2020

    Publikation: Bidrag til tidsskriftTidsskriftartikelFormidling

  3. Nærdødsoplevelser

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Hjertestop hos en patient med langt QT-syndrom i androgendeprivationsterapi

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Leder - Rosenrot

    Publikation: Bidrag til tidsskriftLederForskning

  1. Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: a nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Mortality in patients with Chronic Hepatitis C and cirrhosis compared to the general population - a Danish cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Anna Døssing
  • Birgitte Thorup Røge
  • Lone Galmstrup Madsen
  • Alex Lund Laursen
  • Jesper Bach Hansen
  • Jens Bukh
  • Nina Weis
Vis graf over relationer
In Denmark, about 50% of patients with chronic hepatitis C virus (HCV) infection are undiagnosed. Since 2014, therapy containing direct-acting antivirals (DAA) has proven efficient and is available to all patients, who have a chronic HCV infection and a Danish personal identification number. The World Health Organization has a goal of elimination of viral hepatitis in 2030. Elimination of HCV in Denmark should focus on reducing HCV transmission, incidence and prevalence, combined with treatment with DAA of all infected patients. Micro-elimination strategies may play a major role, but a national strategy is lacking.
Bidragets oversatte titelElimination of hepatitis C virus in Denmark
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind182
Udgave nummer9
ISSN0041-5782
StatusUdgivet - 24 feb. 2020

ID: 62082623